Results 151 to 160 of about 286,424 (258)

Health Disparities in Hepatitis D Virus Management: A Case Series on Improving Patient Access to Bulevirtide Therapy. [PDF]

Gastro Hep Adv
Elsharkawy A, Horobin L, Oakley R, Shah S.   +3 more
europepmc   +1 more source

Reframing Technology and Ethics in Corneal Xenotransplantation: A Scoping Review of Standards and Safety in Ophthalmology

Health Care Science, EarlyView.
Bringing attention to the moral dilemmas raised by xenotransplantation and the continuous creation of standardized frameworks for donor technology and biosafety risk management, with a focus on striking a balance between patient safety, medical innovation, and ethical obligation.
Sankhajyoti Saha, Moubani Dutta, Agnihiya Bosu   +2 more
wiley   +1 more source

Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta. [PDF]

JHEP Rep
Oberhardt V, Degasperi E, Maas M, Borghi M, Heim K, Soffredini R, Anolli MP, Facchetti F, Narguet S, Asselah T, Alizei ES, Sogukpinar Ö, Winkler F, Llewellyn-Lacey S, Emmerich F, Price DA, Boettler T, Bengsch B, Luxenburger H, Hofmann M, Thimme R, Lampertico P, Neumann-Haefelin C.   +22 more
europepmc   +1 more source

A Computed Tomography Radiomics Approach for Assessing the T Cell‐Inflamed Gene Expression Profile in Hepatocellular Carcinoma and Its Association With Immunotherapy Response

Health Care Science, EarlyView.
The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).
Mimi Tang, Kaiyu Sun, Dasheng Wu, Yujian Zou, Jian Zhou, Bin Li, Huanjing Hu, Zhenpeng Peng, Jifei Wang, Bingsheng Huang, Shi‐Ting Feng, Shuling Chen   +11 more
wiley   +1 more source

Updates on Recent Advancements in Hepatitis D Virus Treatment. [PDF]

Viruses
Bardak AE, Ozturk NB, Gurakar M, Sequeira L, Yildiz E, Ozmert EH, Idilman R, Gurakar A.   +7 more
europepmc   +1 more source

Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments. [PDF]

Curr Gastroenterol Rep, 2023
Shekhtman L, Duehren S, Etzion O, Cotler SJ, Dahari H.   +4 more
europepmc   +1 more source

Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania. [PDF]

Diseases
Abdawa M, Hemeyine M, Chemin I, Lunel-Fabiani F, Mohamed Abdellahi MV.   +4 more
europepmc   +1 more source

Analysis of Hepatitis D Virus in Minor Salivary Gland of Sjögren's Disease. [PDF]

J Dent Res, 2023
Hesterman MC, Furrer SV, Fallon BS, Weller ML.   +3 more
europepmc   +1 more source

The Challenge of Hepatitis D Virus Coinfection in Iran: Age, Access, and Unanswered Public Health Questions. [PDF]

Iran J Med Sci
Byeon H.
europepmc   +1 more source

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm. [PDF]

Liver Int
Caviglia GP, Dileo E, Olivero A, Mengozzi G, Ciancio A, Loglio A, Viganò M, Fagiuoli S, Colombatto P, Coco B, Brunetto MR, Angrisani D, Galeota Lanza A, Magni C, Rizzardini G, Messina V, Milella M, Saracino A, Marinaro L, Cariti G, Cossiga V, Morisco F, Cretella S, Verucchi G, Biliotti E, D'Offizi G, Feasi M, Pontali E, Coppola C, Rapetti R, Pirisi M, Izzi A, Santantonio T, Di Marco V, Marrone A, Coppola N, Rizzi M, Cattelan AM, Niro GA, Toniutto P, Ponziani FR, Belli LS, Federico A, Bertino G, Barone M, Puoti M, Civolani A, Distefano M, Surace LA, Cozzolongo R, Cela EM, Teti E, Lampertico P, Stroffolini T, Rizzetto M, HDV Describe Study Group.   +55 more
europepmc   +1 more source